Arul M. Chinnaiyan

Arul M. Chinnaiyan is the S P Hicks Endowed Professor of Pathology and Professor of Urology at the University of Michigan Medical School. He serves as Section Head of the Michigan Center for Translational Pathology and holds center memberships in the Rogel Cancer Center, Precision Health Initiative, Taubman Institute, and others. His research focuses on cancer genomics, prostate cancer mechanisms, and translational pathology, with notable contributions to understanding FOXA1 mutations in prostate tumors and immune checkpoint blockade therapies.

Key research interests include tumor initiation, therapeutic resistance, and the development of diagnostic tools like ERG FISH assays. He actively collaborates on genomic studies of cancers such as high-grade glioma and renal cell carcinoma. His work bridges basic science with clinical applications, emphasizing precision medicine and drug discovery.

Recent publications highlight advancements in single-cell RNA sequencing, targeted therapies for PDGFRA-altered gliomas, and CDK12/13 inhibitors. Awards and recognitions are not explicitly listed, but his leadership roles reflect significant academic impact. Mentoring is emphasized through his 'Available to mentor' status, though specific advisee names are not provided. Research is conducted through his lab at the Michigan Center for Translational Pathology, focusing on actionable insights from genomic data.